| Head and neck cancer (squamous cell carcinoma) |
43.20% |
13,740 |
5936 |
0.97 |
| Esophageal and esophagogastric junction cancer (squamous cell carcinoma & adenocarcinoma) |
33.20% |
15,850 |
5262 |
0.86 |
| Gastric cancer |
33.20% |
10,800 |
3586 |
0.59 |
| Colorectal cancer |
45.70% |
50,630 |
23,138 |
3.8 |
| Anal carcinoma |
54.40% |
1160 |
631 |
0.1 |
| Biliary tract cancers (gallbladder, intrahepatic/extrahepatic cholangiocarcinoma) |
26.10% |
7483 |
1953 |
0.32 |
| Pancreatic adenocarcinoma |
20.40% |
44,330 |
9057 |
1.49 |
| Lung cancer |
39.10% |
154,050 |
60,234 |
9.88 |
| – Small cell carcinoma (12.9%) |
|
19,872 |
7770 |
1.27 |
| – Squamous cell carcinoma (23.2%) |
|
35,740 |
13,974 |
2.29 |
| – Nonsquamous cell carcinoma (63.9%) |
|
98,438 |
38,489 |
6.31 |
| Osteosarcoma |
50.40% |
1590 |
801 |
0.13 |
| Soft tissue sarcomas |
24.50% |
5150 |
1262 |
0.21 |
| Breast cancer |
34.60% |
41,400 |
14,324 |
2.35 |
| Cervical cancer |
42.20% |
4170 |
1760 |
0.29 |
| Uterine cancer |
75.00% |
11,350 |
8513 |
1.4 |
| Ovarian cancer (epithelial, fallopian tube & peritoneal) |
57.40% |
14,070 |
8076 |
1.32 |
| Vulvar cancer (squamous cell carcinoma) |
60.00% |
1200 |
720 |
0.12 |
| Prostate cancer |
14.50% |
29,430 |
4267 |
0.7 |
| Testicular cancer (germ cell tumors) |
73.70% |
400 |
295 |
0.05 |
| Penile cancer |
50.00% |
380 |
190 |
0.03 |
| Bladder (urothelial) cancer |
54.50% |
18,200 |
9919 |
1.63 |
| Central nervous system cancers |
9.20% |
16,830 |
1548 |
0.25 |
| Hodgkin lymphoma |
74.60% |
1050 |
783 |
0.13 |
| Non-Hodgkin lymphoma |
74.20% |
19,910 |
14,773 |
2.42 |
| Acute lymphoblastic leukemia |
90.60% |
1470 |
1332 |
0.22 |
| Chronic lymphocytic leukemia/small lymphocytic leukemia |
58.00% |
4510 |
2616 |
0.43 |
| Acute myeloid leukemia |
76.70% |
10,670 |
8184 |
1.34 |
